Want to see JP:4896 full AI Analyst Report?
K Pharma,Inc. (4896) Financial Statements
K Pharma,Inc. Financial Overview
K Pharma,Inc.'s market cap is currently $8.23B. The company's EPS TTM is $-21.56; its P/E ratio is -7.75; K Pharma,Inc. has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 0.00 | $ 0.00 | $ 1.00B | $ 0.00 | $ 0.00 |
| Gross Profit | $ 0.00 | $ 0.00 | $ 910.00M | $ 0.00 | $ -6.80M |
| Operating Income | $ -916.06M | $ -836.35M | $ 366.06M | $ -353.77M | $ -219.49M |
| EBITDA | $ -983.19M | $ -844.10M | $ 366.06M | $ -390.53M | $ -222.31M |
| Net Income | $ -993.23M | $ -846.46M | $ 260.33M | $ -392.43M | $ -228.72M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 2.79B | $ 2.27B | $ 3.27B | $ 1.34B | $ 188.78M |
| Total Assets | $ 2.94B | $ 2.35B | $ 3.31B | $ 1.37B | $ 205.77M |
| Total Debt | $ 1.50B | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Net Debt | $ -1.29B | $ -2.27B | $ -3.27B | $ -1.34B | $ -188.78M |
| Total Liabilities | $ 1.67B | $ 94.76M | $ 209.13M | $ 38.30M | $ 26.88M |
| Stockholders' Equity | $ 1.27B | $ 2.26B | $ 3.10B | $ 1.34B | $ 178.89M |
| Cash Flow | |||||
| Free Cash Flow | $ -929.19M | $ -998.21M | $ 444.62M | $ -393.44M | $ -196.32M |
| Operating Cash Flow | $ -918.00M | $ -983.72M | $ 454.43M | $ -363.48M | $ -196.32M |
| Investing Cash Flow | $ -54.68M | $ -14.49M | $ -11.10M | $ -32.74M | $ -250.00K |
| Financing Cash Flow | $ 1.50B | $ 0.00 | $ 1.49B | $ 1.54B | $ 368.20M |
Currency in JPY
